Hims & Hers Health (HIMS) Revenue (2020 - 2026)
Hims & Hers Health (HIMS) reported Revenue of $608.1 million for Q1 2026, up 3.77% on a YoY basis from $586.0 million in Q1 2025, and down 1.57% sequentially from $617.8 million in Q4 2025.
Hims & Hers Health (HIMS) Revenue (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Revenue data on file, last reported at $608.1 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 3.77% year-over-year to $608.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 billion (up 32.81% YoY), and the FY2025 full-year result was $2.3 billion, up 59.0% from the prior year.
- Revenue retreated to $608.1 million in Q1 2026, from $617.8 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $617.8 million in Q4 2025 to a low of $101.3 million in Q1 2022.
- A 5-year average of $343.0 million and a median of $278.2 million in 2024 frame the typical range for Revenue.
- Across the five-year window, Revenue soared 110.67% in 2025 and rose 3.77% in 2026, its largest moves.
- Tracing HIMS's Revenue over 5 years: stood at $167.2 million in 2022, then jumped by 47.5% to $246.6 million in 2023, then jumped by 95.09% to $481.1 million in 2024, then grew by 28.41% to $617.8 million in 2025, then declined by 1.57% to $608.1 million in 2026.
- Business Quant data shows HIMS's Revenue at $608.1 million in Q1 2026, $617.8 million in Q4 2025, and $599.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 608.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 608.10 Mn |
| Dec 31, 2025 | 617.82 Mn |
| Sep 30, 2025 | 598.98 Mn |
| Jun 30, 2025 | 544.83 Mn |
| Mar 31, 2025 | 586.01 Mn |
| Dec 31, 2024 | 481.14 Mn |
| Sep 30, 2024 | 401.56 Mn |
| Jun 30, 2024 | 315.65 Mn |
| Mar 31, 2024 | 278.17 Mn |
| Dec 31, 2023 | 246.62 Mn |
| Sep 30, 2023 | 226.70 Mn |
| Jun 30, 2023 | 207.91 Mn |
| Mar 31, 2023 | 190.77 Mn |
| Dec 31, 2022 | 167.20 Mn |
| Sep 30, 2022 | 144.84 Mn |
| Jun 30, 2022 | 113.56 Mn |
| Mar 31, 2022 | 101.31 Mn |
| Dec 31, 2021 | 84.70 Mn |
| Sep 30, 2021 | 74.17 Mn |
| Jun 30, 2021 | 60.69 Mn |